Recently, the prices of Chinese patent medicines of several well-known pharmaceutical enterprises in China have increased, including some common varieties. So what is the reason for the price increase?
0 1
the price of medicinal materials rises
Chinese patent medicines have raised prices
In a pharmacy in Shenzhen, the reporter found that the price of Beijing Tongrentang Co.Ltd(600085) Angong Niuhuang Pill had just increased from 780 yuan per box to 860 yuan, an increase of about 10%. The salesperson revealed that this is a national price increase at the beginning of this month. In a drugstore in Anguo, Hebei Province, the person in charge said that since December, several common proprietary Chinese medicines of many well-known pharmaceutical enterprises have raised their prices, with an increase of 10% to 20% .
In Beijing, Hebei, Guangdong and other markets, the reporter found that the price of more than a dozen kinds of Chinese patent medicines. Industry insiders said that the main reason for the rise in the price of proprietary Chinese medicine is the general rise in the price of traditional Chinese medicine. take Angong Niuhuang Pill as an example, the prices of all 11 components of traditional Chinese medicine increased by 20% to 50% .
Dynasty, head of a traditional Chinese medicine enterprise in Hebei: bezoar rose by nearly 40% to 50%, and the price of natural musk was also particularly high.
The reporter learned from the drugstore that the sales of most Chinese patent medicines with rising prices have not been affected, and even the Chinese patent medicines of some well-known pharmaceutical enterprises are in short supply .
02
Anguo, Hebei: nearly 80% of the prices of medicinal materials have increased
the transaction is slightly deserted
The rise in the price of traditional Chinese medicine has led to an increase in the price of end products. Is the price rise of traditional Chinese medicine a common phenomenon? What causes the price rise of traditional Chinese medicine? The reporter conducted an investigation in Anguo, Hebei, the largest trading center of traditional Chinese medicine in northern China.
In Hebei Anguo traditional Chinese medicine trading market, although it is morning time, not many merchants come to purchase. Some operators told reporters that since December, nearly 80% of the prices of traditional Chinese medicine have risen, and many customers have a wait-and-see attitude, so the trading volume has declined . For example, the prices of common Coptis, honeysuckle and scutellaria have increased to varying degrees.
Wang Huawei, a merchant of Hebei Anguo traditional Chinese medicine trading market: Yujin will be sold in July because of new production. Everyone is eager to sell it as soon as it is harvested. The grower with 29 yuan will sell it if it is enough. Later, as long as the acquirer wanted it, it rose to 42 yuan.
In addition to common varieties, the price of some expensive fine medicinal materials has increased more obviously. The reporter noted that the prices of saffron, pilose antler, bird’s nest, American ginseng, Cordyceps and other varieties increased by 10% to 50% .
After combing, the reporter found that among the types of price increases, there is another kind of homologous varieties of newly imported medicine and food, such as tangerine peel, Dendrobium, etc. The reporter learned in Hebei market that after tangerine peel entered the same source of medicine and food, the demand increased, resulting in short supply. The price of new tangerine peel has risen from 5 yuan per kilogram at the beginning of this year to about 10 yuan now .
03
store raw materials in advance and lock profits early
large pharmaceutical enterprises focus on centralized purchase opportunities
Under the pressure of rising raw material prices, how should downstream Chinese patent medicine manufacturers deal with it?
In a pharmaceutical enterprise in Hebei, the person in charge of the procurement department said that the number of Chinese herbal medicines used in more than 30 kinds of Chinese patent medicines produced by them is as much as 400 kinds. At present, more than 80% of the varieties have started to increase their prices since the first half of the year. in order to cope with the price rise, they hoard in advance from the second half of the year. More than 50 tons of raw land were purchased in July this year, at that time, it was more than 20 yuan per kilogram, but now it has risen to nearly 60 yuan per kilogram .
In order to avoid the decline in revenue caused by the rise in the price of traditional Chinese medicine, some Chinese patent medicine enterprises adjust their sales strategies from short-term contracts to long-term contracts, so as to lock in profits in advance.
Wang Yi, deputy general manager of a traditional Chinese medicine production enterprise in Hebei: purchase from the source, mainly to the planting base of the origin and large cooperatives, and extend the procurement channels to reduce the procurement cost.
In the context of rising raw material prices, many large pharmaceutical enterprises see the opportunities behind the centralized purchase of Chinese patent medicines. In a traditional Chinese medicine production enterprise in Hebei, the reporter saw that although it was time to get off work, all three workshops of the enterprise were working overtime. The person in charge said that this was because the large-scale centralized purchase of traditional Chinese medicine had begun, and the rising cost of traditional Chinese medicine made some small enterprises unable to participate, but it was an opportunity for large-scale enterprises. Therefore, They recently increased production to seize the market ahead of time.
(China Central Television Finance)
